Skip to main content
. 2024 May 1;9(6):e10673. doi: 10.1002/btm2.10673

FIGURE 4.

FIGURE 4

Distribution of indications and active ingredients, approval trends in FDA approved hemostats. (a) Number of hemostats approved per indication. (b) Number of hemostat approvals per decade. AAV, adeno‐associated virus; CF, coagulation factor; vWF, von Willebrand factor.